MREO
Mereo BioPharma
MREO
MREO
58 hedge funds and large institutions have $43M invested in Mereo BioPharma in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
15
Reduced
14
Closed
10
Calls
$54K
Puts
–
Net Calls
+$54K
Net Calls Change
+$48K
Top Buyers
| 1 |
6CM
1
683 Capital Management
New York
|
$1.41M |
| 2 |
2
Millennium Management
New York
|
$1.77M |
| 3 |
3
Citigroup
New York
|
$799K |
| 4 |
BFM
4
Boothbay Fund Management
New York
|
$302K |
| 5 |
JGC
5
J. Goldman & Co
New York
|
$429K |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$5.48M |
| 2 |
AG
2
Artal Group
Luxembourg
|
$0 |
| 3 |
OCA
3
Octagon Capital Advisors
New York
|
$0 |
| 4 |
MAM
4
Monaco Asset Management
Monaco
|
$930K |
| 5 |
5
Renaissance Technologies
New York
|
$647K |
